Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

Polyphenols in plant foods help prevent diseases and have potential uses in food, cosmetics, and more.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

A child on life support experienced rapid hair loss due to severe illness affecting hair growth.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

People undergoing chemotherapy need better support and information to cope with hair loss.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Using ultrasound may make cisplatin more effective against cervical cancer in mice.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Some breast cancer chemotherapy can cause permanent hair loss.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Scalp cooling effectively prevents hair loss during chemotherapy in most cases.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.